This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Victor Herbert, MD, JD
Mount Sinai and Bronx VA Medical Centers Bronx, NY

JAMA. 1997;277(11):880.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Dr Clark and colleagues¹ informed us that while, compared with a placebo, selenium supplements reduced overall cancer morbidity and mortality, they did not reduce all-cause morbidity and mortality. This indicates that selenium increased morbidity and mortality from diseases other than cancer. So that we can adequately inform our patients, Clark et al should tell us what those other diseases are and by how much their morbidity and mortality were increased by the selenium supplements. Patients susceptible to those other diseases may be as much harmed by taking selenium supplements as those susceptible to certain cancers may be helped. . . . [Full Text PDF of this Article]

Footnotes
Edited by Margaret A. Wirker, MD. Senior Editor, and Phil B. Fontanaraosa, MD, Senior Editor.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?